These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11986992)

  • 1. Delayed pharmacological effects of antidepressants.
    Frazer A; Benmansour S
    Mol Psychiatry; 2002; 7 Suppl 1():S23-8. PubMed ID: 11986992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic antidepressant treatment alters serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons.
    Zhong P; Yan Z
    Neuroscience; 2004; 129(1):65-73. PubMed ID: 15489029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant effects assessed using behavior maintained under a differential-reinforcement-of-low-rate (DRL) operant schedule.
    O'Donnell JM; Marek GJ; Seiden LS
    Neurosci Biobehav Rev; 2005; 29(4-5):785-98. PubMed ID: 15893376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological effects of serotonin reuptake inhibitors.
    Leonard BE
    J Clin Psychiatry; 1988 Aug; 49 Suppl():12-7. PubMed ID: 3045106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M; David DJ; Jolliet P; Gardier A
    Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the chronic treatment effects of venlafaxine and other antidepressants on serotonin and norepinephrine transporters.
    Gould GG; Altamirano AV; Javors MA; Frazer A
    Biol Psychiatry; 2006 Mar; 59(5):408-14. PubMed ID: 16140280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The serotonergic and noradrenergic effects of antidepressant drugs are anticonvulsant, not proconvulsant.
    Jobe PC; Browning RA
    Epilepsy Behav; 2005 Dec; 7(4):602-19. PubMed ID: 16169281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050.
    Shaw AM; Boules M; Zhang Y; Williams K; Robinson J; Carlier PR; Richelson E
    Eur J Pharmacol; 2007 Jan; 555(1):30-6. PubMed ID: 17109850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a biochemical lesion in depression.
    Leonard BE
    J Clin Psychiatry; 2000; 61 Suppl 6():12-7. PubMed ID: 10775019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine.
    Burghardt NS; Sullivan GM; McEwen BS; Gorman JM; LeDoux JE
    Biol Psychiatry; 2004 Jun; 55(12):1171-8. PubMed ID: 15184036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pharmacologically selective antidepressants on serotonin uptake in rat platelets.
    Fisar Z; Anders M; Kalisová L
    Gen Physiol Biophys; 2005 Mar; 24(1):113-28. PubMed ID: 15900091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nonselective effect of selective antidepressants.
    Montgomery SA
    Adv Biochem Psychopharmacol; 1982; 32():49-55. PubMed ID: 6178265
    [No Abstract]   [Full Text] [Related]  

  • 13. Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor.
    Eisensamer B; Rammes G; Gimpl G; Shapa M; Ferrari U; Hapfelmeier G; Bondy B; Parsons C; Gilling K; Zieglgänsberger W; Holsboer F; Rupprecht R
    Mol Psychiatry; 2003 Nov; 8(12):994-1007. PubMed ID: 14647397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressants and somatic symptoms: therapeutic actions are expanding beyond affective spectrum disorders to functional somatic syndromes.
    Stahl SM
    J Clin Psychiatry; 2003 Jul; 64(7):745-6. PubMed ID: 12934972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deamplification of noradrenergic signal transfer by antidepressants: a unified catecholamine-serotonin hypothesis of affective disorders.
    Sulser F
    Psychopharmacol Bull; 1983; 19(3):300-4. PubMed ID: 6635110
    [No Abstract]   [Full Text] [Related]  

  • 16. Affective disorder and epilepsy comorbidity: implications for development of treatments, preventions and diagnostic approaches.
    Jobe PC
    Clin EEG Neurosci; 2004 Jan; 35(1):53-68. PubMed ID: 15112464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between Recurrent Falls and Medication Use during Acute-Care Hospitalization: A Retrospective Descriptive Study.
    Hirai T; Ishikawa Y; Kawagoe Y; Ogawa Y; Ogawa R; Itoh T
    Biol Pharm Bull; 2019; 42(7):1192-1198. PubMed ID: 31257294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain norepinephrine system as a target for antidepressant and mood stabilizing medications.
    Dremencov E; el Mansari M; Blier P
    Curr Drug Targets; 2009 Nov; 10(11):1061-8. PubMed ID: 19702556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin 1A and Serotonin 4 Receptors: Essential Mediators of the Neurogenic and Behavioral Actions of Antidepressants.
    Samuels BA; Mendez-David I; Faye C; David SA; Pierz KA; Gardier AM; Hen R; David DJ
    Neuroscientist; 2016 Feb; 22(1):26-45. PubMed ID: 25488850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain noradrenergic neurons, their interactions and role in the action of antidepressive drugs.
    Kostowski W
    Acta Physiol Pharmacol Bulg; 1982; 8(1-2):29-36. PubMed ID: 7124417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.